Vol 71, No 6 (2020)
Clinical vignette
Published online: 2020-09-25

open access

Page views 718
Article views/downloads 693
Get Citation

Connect on Social Media

Connect on Social Media

Endoscopic ultrasound-guided ethanol ablation of insulinoma

Ewa Zalewska1, Przemysław Kłosowski1, Michał Dubowik2, Rafał Pęksa3, Krzysztof Sworczak1
Pubmed: 33125699
Endokrynol Pol 2020;71(6):585-586.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Buicko JL, Finnerty BM, Zhang T, et al. Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors. Ann Pancreat Cancer. 2019; 2.
  2. Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, et al. Consensus Conference, olish Network of Neuroendocrine Tumours. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2013; 64(6): 459–479.
  3. Barthet M, Giovannini M, Lesavre N, et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy. 2019; 51(9): 836–842.
  4. Mele C, Brunani A, Damascelli B, et al. Non-surgical ablative therapies for inoperable benign insulinoma. J Endocrinol Invest. 2018; 41(2): 153–162.
  5. Dąbkowski K, Gajewska P, Walter K, et al. Successful EUS-guided ethanol ablation of insulinoma, four-year follow-up. Case report and literature review. Endokrynol Pol. 2017; 68(4): 472–479.